Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled Clinical Study on the Activity of the Combination of Isoflavones, Agnocastus and Magnolia Extract in Menopause

NCT01730989 is registered in ClinicalTrials.gov with Rottapharm as lead sponsor.

NCT NCT01730989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01730989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled Clinical Study on the Activity of the Combination of Isoflavones, Agnocastus and Magnolia Extract in Menopause
Lead sponsor
Rottapharm
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2012
Completion date
November 30, 2013
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menopause